Cours Immunoprecise Antibodies Ltd Toronto S.E.
Actions
TQY
CA87588T2020
Produits pharmaceutiques
CA 2024 * | 24,59 M 17,97 M 16,04 M | CA 2025 * | 29,82 M 21,8 M 19,46 M | Capitalisation | 38,17 M 27,9 M 24,9 M |
---|---|---|---|---|---|
Résultat net 2024 * | -12 M -8,77 M -7,83 M | Résultat net 2025 * | -9 M -6,58 M -5,87 M | VE / CA 2024 * | 1,55 x |
Trésorerie nette 2024 * | - 0 0 | Trésorerie nette 2025 * | - 0 0 | VE / CA 2025 * | 1,28 x |
PER 2024 * |
-3,02
x | PER 2025 * |
-4,09
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 86,41% |
Dernier transcript sur Immunoprecise Antibodies Ltd
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Kristin Taylor
DFI | Director of Finance/CFO | - | 29/09/23 |
Ilse Roodink
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mitchell Levine
CHM | Chairman | - | - |
Chris Buyse
BRD | Director/Board Member | 59 | 05/09/23 |
Jennifer Bath
CEO | Chief Executive Officer | - | 21/02/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
-0,28% | 90,59 Md | |
-0,92% | 38,99 Md | |
-9,57% | 34,09 Md | |
-17,98% | 15,02 Md | |
-6,74% | 13,17 Md | |
-9,76% | 11,88 Md | |
-47,31% | 10,65 Md | |
+7,12% | 9,25 Md | |
+137,06% | 9,02 Md |